| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.4M | +6.3% |
| Cost of Revenue | $3.8M | -41.1% |
| R&D Expense | $1.8M | -37.2% |
| SG&A Expense | $11.6M | -22.6% |
| Operating Income | -$7.7M | +57.0% |
| Interest Expense | $2.2M | -1.2% |
| Pre-tax Income | -$8.9M | -116.7% |
| Income Tax | $17K | +0.0% |
| Net Income | -$8.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $9.8M | +71.3% |
| Inventory | $1.6M | -7.1% |
| Current Assets | $13.6M | +47.8% |
| Total Assets | $23.8M | +125.4% |
| Current Liabilities | $80.4M | +11.0% |
| Total Liabilities | $90.3M | +24.6% |
| Stockholders' Equity | -$71.3M | -7.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.9M | +56.7% |
| Capital Expenditures | $14K | +250.0% |
| Investing Cash Flow | -$569K | — |
| Financing Cash Flow | $4.6M | -3.4% |
| Free Cash Flow | -$3.9M | +56.5% |
| -116.7% |
| EPS (Basic) | -$0.12 | -101.2% |
| EPS (Diluted) | -$0.12 | -340.0% |